Biotech2k Profile picture
Jul 10 21 tweets 4 min read
#Oncogenetics Part 3:

This will cover Tumor Suppressor and Onco-Genes.
1/ Now we covered the DNA repair genes that validate the integrity of the DNA, we can look at the growth pathway genes that move the cell through the growth cycle into mitosis.
2/ There are two sets of genes with the Tumor Suppressor Genes and the Proto Oncogenes. The tumor suppressors act like the breaks. They are there to prevent the cell from moving through the cycle until they get a signal to allow it to do so.
3/ The tumor suppressor genes stop movement through the cycle. Some of the most important suppressor genes work along with the DNA repair genes to ensure the DNA is ready and safe to be duplicated.
4/ These are genes like p53, p21 and Rb. The p53 gene is called the guardian of the genome as it senses signals from the DNA repair pathways and prevents cell replication unless all things are good. Any issues with the DNA will activate p53 and block cell replication.
5/ p53 is a key regulator that sits between the DNA repair pathway and the cell cycle pathways. It can arrest the cell cycle and even initiate Apoptosis which is programmed cell death. The level of p53 activation depends on the level of damage.
6/ It is shown that over 50% of all cancers have a mutation in p53 that cause a loss of function. That is what we call mutations in Tumor suppressor genes like p53 or Rb. They lose their function when they no longer work.
7/ Loss of function mutations are often where most cancers start. We get two copies of each gene. One comes from mom and the other from dad. That means you get two of the p53 and two of the Rb genes. If even one of them is working, you still have function enough for it to work.
8/ This bring us to the concept of the Two Hit Hypothesis. This means you need to lose both copies of a tumor suppressor gene to lose their function. Mutations in these gene lead to them losing function.
9/ Next are the Proto Oncogenes. They are called proto oncogenes when they are healthy. They become oncogenes when they mutate and drive cancer. These are the genes that are activated to push the cell through the growth cycle. They act like the gas peddle.
10/ It only takes a mutation in one proto oncogene to drive cancer. Many of them will work independent of any signaling staying in an always on state. This drives uncontrolled cell growth.
11/ Many of these genes we hear about all the time like RAS. Its is estimated that RAS mutations are genetic drivers in over 30% of all cancers.
12/ There are two major growth pathways in all cells that drive them through the cell cycle. These are the MAPK pathway made up of RAS, RAF, MEK and ERK and the mTOR pathway made up of PI3K, AKT and mTOR.
13/ When it comes to beating cancer, and ounce of prevention is truly worth a pound of cure. We have seen this from the annual screening programs we use today for Breast and Prostate cancer.
14/ These programs don't not prevent the formation of new cancers, but they catch them early when they can be easily treated. Early screening has save more lives in breast and prostate cancer than any single drug.
15/ Screening in Colorectal Cancer is another place where screening can catch a deadly cancer early and save lives. This is great for these indications, but many indications still have no screening tests.
16/ The liver is one of those cancers where it often goes asymptomatic until it is way too late. Being able to screen can detect early cancers in all tissues would be a game changer. This will be the biggest way to impact the survival in cancer.
17/ This is where tests like liquid biopsies and testing companies that test and track this data could play a huge role in the future treatment of cancer. Every patient that can be screened annually and detected can be treated before the cancer goes to far.
18/ We may never be able to cure cancer as its genetic mutations. The level of mutation in each cell of a single tumor is vast. The level of genetic variation from patient to patient makes curing cancer next to impossible.
19/ It takes only 1 cell to survive and the whole tumor can regrow. We may never beat cancer with a cure, but we might someday get to the point where its a non life threating chronic disease. This can be done with strong early detection and annual screening programs.
20/ Cancer might not be beaten, but it might someday be manageable.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Biotech2k

Biotech2k Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @Biotech2k1

Jul 10
#Oncogenetics Part 2:

Genomic Instability.
1/ When it comes to cancer genetics, I am sure we have all heard of Onco-genes or Tumor Suppressor genes. There is another set of critical genes in controlling cancer that most people haven't really heard about.
2/ These are the genes that control the many proteins and enzymes that regulate the integrity of the DNA itself.
Read 16 tweets
Jul 10
#Oncogenetics Part 1:

This will be an introduction with the biology of oncology. Then I plan to get into the genetics. I will then come back and do a walkthrough example of how genetics drive the development of a tumor.
1/ Cancer doesn't start with just 1 mutation. It is an accumulation of mutations over time. It starts with just one cell that develops a mutation which gives it an advantage to grow.
2/ That cell replicates faster than other cells around it or it replicates when its not supposed to. As it continues to divide, it will eventually gain more beneficial mutations which move it down the path toward cancer.
Read 22 tweets
Jul 10
1/ Some of the more common CD indicators and what they are for.
2/
CD-1 = Used in some Immune cells to as a receptor for recegnizing lipid pathogens
CD-3 = It is part of the T cell receptor complex for transducing the signal
CD-4 = This is the co-receptor for Helper T cells receptors
3/
CD-8 = This is the co-receptor for Cytotoxic T cell receptors
CD-11 = Part of the Leukocyte adhesion molecule along with CD-18
CD-16 = The antibody receptor for the Fc portion of antibodies
CD-18 = Part of the Leukocyte adhesion molecule along with CD-11
Read 7 tweets
Jul 9
1/ Gene Editing Part 2:

This will cover CRISPR.
2/ CRISPR comes in the same 2 basic parts as any other gene editor. It has the guide built from RNA which feeds into the CAS nuclease which does the cutting.
3/ CAS enzyme will wrap around the DNA and open it up. It will run the RNA based guide along one of the strands until it finds the match for its guide. It has a second site specific guide built into it call a PAM sequence.
Read 22 tweets
Jul 9
1/ Gene Editing Part 1:

This will look over the different editing technologies of ZFN, TALEN and CRISPR. It will include a basic overview of the science and how it works. I will include some advantages and disadvantages along with personal comments from past experience.
2/ Common Attributes:

The most common attribute of these editors is the introduction of a double stranded break (DSB). This causes the use of Non-Homologous End Joining (NHEJ) DNA repair. This can cause insertions or deletions of random bases in the DNA from the repair.
3/ We call these insertions and deletions (Indels). They can lead to mutations which will potentially cause cancer. These technologies work well for gene knockouts where the mutation is the goal. A knocked out gene does not get translated into protein.
Read 19 tweets
Jul 8
$XBI is now up over 32% from its double bottoms around $62 to $63. It surely looks to want to run to $90 or even the mid 90's before it will run into some resistance. Its been a big move in a lot of really beaten down stocks.
When we get to $90, that is when you should look at just raising a little cash. May plan if we get to that range is to dump my worst company so I can rotate that cash into other companies when we give back some of this move in the fall.
This is part of my plan into the biotech recovery to maximize my taxes by selling only the losers and realizing the losses and keeping the winners long term for the lower long term cap gains benefits. It is also sound strategy.
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(